nodes	percent_of_prediction	percent_of_DWPC	metapath
Emtricitabine—DCK—Purine salvage—APRT—nephrolithiasis	0.209	0.544	CbGpPWpGaD
Emtricitabine—DCK—Purine metabolism—APRT—nephrolithiasis	0.0992	0.258	CbGpPWpGaD
Emtricitabine—DCK—Nucleotide metabolism—APRT—nephrolithiasis	0.0499	0.13	CbGpPWpGaD
Emtricitabine—Creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.0354	0.0575	CcSEcCtD
Emtricitabine—Nephritis interstitial—Hydrochlorothiazide—nephrolithiasis	0.0275	0.0447	CcSEcCtD
Emtricitabine—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.027	0.0439	CcSEcCtD
Emtricitabine—Tubulointerstitial nephritis—Hydrochlorothiazide—nephrolithiasis	0.0243	0.0394	CcSEcCtD
Emtricitabine—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.0229	0.0373	CcSEcCtD
Emtricitabine—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.021	0.0341	CcSEcCtD
Emtricitabine—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.0197	0.0319	CcSEcCtD
Emtricitabine—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.0194	0.0315	CcSEcCtD
Emtricitabine—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.0168	0.0273	CcSEcCtD
Emtricitabine—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.0154	0.025	CcSEcCtD
Emtricitabine—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.0152	0.0247	CcSEcCtD
Emtricitabine—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.0142	0.023	CcSEcCtD
Emtricitabine—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.0126	0.0205	CcSEcCtD
Emtricitabine—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.0123	0.02	CcSEcCtD
Emtricitabine—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0198	CcSEcCtD
Emtricitabine—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0193	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0193	CcSEcCtD
Emtricitabine—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0186	CcSEcCtD
Emtricitabine—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0177	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.0108	0.0176	CcSEcCtD
Emtricitabine—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0171	CcSEcCtD
Emtricitabine—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.0105	0.017	CcSEcCtD
Emtricitabine—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0166	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0166	CcSEcCtD
Emtricitabine—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0164	CcSEcCtD
Emtricitabine—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00991	0.0161	CcSEcCtD
Emtricitabine—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00976	0.0159	CcSEcCtD
Emtricitabine—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00936	0.0152	CcSEcCtD
Emtricitabine—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00934	0.0152	CcSEcCtD
Emtricitabine—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00926	0.0151	CcSEcCtD
Emtricitabine—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00786	0.0128	CcSEcCtD
Emtricitabine—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00751	0.0122	CcSEcCtD
Emtricitabine—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00743	0.0121	CcSEcCtD
Emtricitabine—Cough—Hydrochlorothiazide—nephrolithiasis	0.00709	0.0115	CcSEcCtD
Emtricitabine—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00692	0.0112	CcSEcCtD
Emtricitabine—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00692	0.0112	CcSEcCtD
Emtricitabine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00689	0.0112	CcSEcCtD
Emtricitabine—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00649	0.0106	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00604	0.00982	CcSEcCtD
Emtricitabine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.006	0.00975	CcSEcCtD
Emtricitabine—DCK—Metabolism—GRHPR—nephrolithiasis	0.00598	0.0155	CbGpPWpGaD
Emtricitabine—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00596	0.00968	CcSEcCtD
Emtricitabine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00591	0.00961	CcSEcCtD
Emtricitabine—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00584	0.00949	CcSEcCtD
Emtricitabine—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00572	0.00929	CcSEcCtD
Emtricitabine—Pain—Hydrochlorothiazide—nephrolithiasis	0.00567	0.00922	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00542	0.00881	CcSEcCtD
Emtricitabine—DCK—Metabolism—AGXT—nephrolithiasis	0.00533	0.0138	CbGpPWpGaD
Emtricitabine—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00527	0.00856	CcSEcCtD
Emtricitabine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00524	0.00852	CcSEcCtD
Emtricitabine—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00524	0.00852	CcSEcCtD
Emtricitabine—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00489	0.00794	CcSEcCtD
Emtricitabine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00476	0.00773	CcSEcCtD
Emtricitabine—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00469	0.00762	CcSEcCtD
Emtricitabine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00454	0.00737	CcSEcCtD
Emtricitabine—DCK—Metabolism—SLC26A1—nephrolithiasis	0.00453	0.0118	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—APRT—nephrolithiasis	0.00453	0.0118	CbGpPWpGaD
Emtricitabine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00439	0.00713	CcSEcCtD
Emtricitabine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00422	0.00685	CcSEcCtD
Emtricitabine—Rash—Hydrochlorothiazide—nephrolithiasis	0.00418	0.0068	CcSEcCtD
Emtricitabine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00418	0.00679	CcSEcCtD
Emtricitabine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00415	0.00675	CcSEcCtD
Emtricitabine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00394	0.0064	CcSEcCtD
Emtricitabine—DCK—Metabolism—AQP1—nephrolithiasis	0.00323	0.00839	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—CHRM3—nephrolithiasis	0.00292	0.00759	CbGpPWpGaD
